Skip to content
★ Sign in to follow
EK

Elaine K. Sorg

Chief Operating Officer
Total declarations
42
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (18 ops.)
€14.0M

Latest filing published 27 Apr 2023 for AbbVie Inc., €807k.

Filing timeline

BuySale
Elaine K. Sorg

Insider track record

Disclosed buys
0
Disclosed sells
18

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Elaine K. Sorg: trading record in brief

Elaine K. Sorg is a declared insider of AbbVie Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 18 February 2021 to 25 April 2023, the count stands at 42 filings.

Every open-market trade on record is a sale: 18 sales worth €14.0M. Other entries cover 17 share grants and 7 option exercises. So far in 2023, the count stands at no purchases and 7 sales.

On 27 April 2023 came the latest disclosure, an open-market sale for €921k in AbbVie Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Elaine K. Sorg

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◇
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    886,030 USD23SEC
    6,130 shares@ US$144.546.0% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-006965:0
  • ▼
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    1M USD23SEC
    6,999 shares@ US$161.647.6% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-006720:0
  • ◇
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    1M USD23SEC
    15,002 shares@ US$93.509.5% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-006301:0
  • ◆
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    3M USD24SEC
    19,850 shares@ US$154.2821.3% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-003856:0
  • ◇
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    2M USD23SEC
    15,321 shares@ US$105.9211.2% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-002944:4
  • ▼
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    1M USD41SEC
    6,901 shares@ US$150.747.2% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-002944:5
  • ▼
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    1M USD41SEC
    8,420 shares@ US$151.298.8% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-002944:6
  • ◆
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    0SEC
    29,410 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002944:0
  • ◆
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    0SEC
    6,861 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002944:1
  • ◆
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    0SEC
    4,658 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002944:2
  • ◆
    SVP, US COMMERCIAL OPERATIONSExecutivesAbbVie Inc.
    0SEC
    3,874 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002944:3
  • ◆
    SVP, US Commercial OperationsExecutivesAbbVie Inc.
    2M USD12SEC
    11,125 shares@ US$149.5412.0% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-001837:0
  • ◆
    SVP, US Commercial OperationsExecutivesAbbVie Inc.
    0SEC
    11,642 shares0Common Stock, $0.01 par valueSEC:0001179110-22-001518:0
  • ◆
    SVP, US Commercial OperationsExecutivesAbbVie Inc.
    637,759 USD11SEC
    5,137 shares@ US$124.154.6% of flowCommon Stock, $0.01 par valueSEC:0001179110-21-010958:0
  • ▼
    SVP, US Commercial OperationsExecutivesAbbVie Inc.
    720,000 USD23SEC
    6,000 shares@ US$120.005.0% of flowCommon Stock, $0.01 par valueSEC:0001179110-21-008421:0

15 of 15 declarations